BIO-RAD LABORATORIES-A (BIO) Stock News

NYSE:BIO - US0905722072 - Common Stock

289.86 USD

-5.57 (-1.89%)

Last: 9/8/2025, 12:21:10 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BIO Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Yahoo Finance

Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery?

7 days ago - By: Zacks Investment Research - Mentions: MASI PAHC NVST

Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?

14 days ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad's Management to Participate in Upcoming Investor Conferences

a month ago - By: The Motley Fool

Bio-Rad (BIO) Q2 EPS Jumps 51%

a month ago - By: Benzinga - Mentions: BSAC BGC RMNI MTZ ...

Earnings Scheduled For July 31, 2025

3 months ago - By: Benzinga

5 Analysts Have This To Say About Bio-Rad Laboratories

a month ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

a month ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad Reports Second-Quarter 2025 Financial Results

a month ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations

a month ago - By: Yahoo Finance

Bio-Rad Laboratories, Inc. (BIO) Launches New Digital PCR Systems in 2025

2 months ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025

2 months ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout

3 months ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference

4 months ago - By: Zacks Investment Research

Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends

4 months ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

4 months ago - By: Zacks Investment Research - Mentions: ANGO MASI VEEV

BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket

4 months ago - By: Zacks Investment Research - Mentions: OGI

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates

4 months ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad Reports First-Quarter 2025 Financial Results

4 months ago - By: Yahoo Finance - Mentions: DHI CMG

Bio-Rad Laboratories, Inc. (BIO): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential

5 months ago - By: Zacks Investment Research

Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for

5 months ago - By: Biodesix, Inc. - Mentions: BDSX

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

5 months ago - By: Yahoo Finance - Mentions: TSLA

Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile?

5 months ago - By: Yahoo Finance

Should You be Optimistic on Bio-Rad Laboratories’s (BIO) Outlook?

5 months ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

5 months ago - By: Zacks Investment Research - Mentions: TMO QGEN TECH

Bio-Techne Opens New Customer Experience Centre in Germany

5 months ago - By: Zacks Investment Research - Mentions: ABT TMO CRL

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

7 months ago - By: Bio-Rad Laboratories, Inc. - Mentions: BIOB

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results